fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people – AstraZeneca

Written by | 14 Aug 2021

In a large real-world study, data published as a pre-print on The Lancet server from over one million individuals assessed the incidence rates of blood clotting disorders of… read more.

Community pharmacies – ‘most essential’ local service

Written by | 14 Aug 2021

Community pharmacies have been rated the number 1 most essential local service in the 2021 Community Barometer, a poll conducted by the Association of Convenience Stores. The 2021… read more.

FDA accepts sBLA for Keytruda in high-risk stage II melanoma – Merck Inc

Written by | 13 Aug 2021

Merck Inc announced that the Phase III KEYNOTE-716 trial investigating Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, met its primary endpoint of recurrence-free survival (RFS) for the adjuvant treatment of… read more.

New discovery explains antihypertensive properties of green and black tea

Written by | 13 Aug 2021

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the… read more.

BMS statement on Istodax for relapsed/refractory peripheral T-cell lymphoma FDA Indication

Written by | 12 Aug 2021

In 2011, Celgene Corporation, now a wholly owned subsidiary of Bristol Myers Squibb, received accelerated approval by the FDA for Istoda (romidepsin), a histone deacetylase (HDAC) inhibitor, as… read more.

People who have trouble sleeping are at a higher risk of dying early – especially diabetics

Written by | 12 Aug 2021

In a paper published by the Journal of Sleep Research, researchers reveal how they examined data* from half a million middle-aged UK participants asked if they had trouble falling… read more.

Applying the results of the ivermectin meta-analysis

Written by | 12 Aug 2021

The results of the ivermectin meta-analysis could have important implications for health policy. Dr Edmund Fordham, one of the co-authors of the review, describes how the findings could… read more.

Critical questions on the ivermectin meta-analysis

Written by | 12 Aug 2021

The methodological approach to the ivermectin meta-analysis provides further reassurance of the robustness of the findings. Mr Andrew Bryant and Dr Edmund Fordham describe some of the critical… read more.

Putting the findings of the ivermectin meta-analysis into perspective

Written by | 12 Aug 2021

The Bryant-Lawrie meta-analysis included only randomised controlled trials (RCTs) but evidence from observational trials and real world experience sheds further light on the effectiveness of ivermectin, according to… read more.

Key findings from the ivermectin meta-analysis

Written by | 12 Aug 2021

June 2021 saw the publication of the systematic review and meta-analysis of randomised controlled trials of ivermectin for treatment and prophylaxis of covid-19 undertaken by Dr Tess Lawrie’s… read more.

FDA approves fexinidazole as the first all-oral treatment for sleeping sickness – Sanofi + DNDi

Written by | 11 Aug 2021

The FDA has approved fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness (Human African trypanosomiasis) in patients 6… read more.

A fermented-food diet increases microbiome diversity and lowers inflammation, study finds

Written by | 11 Aug 2021

A diet rich in fermented foods enhances the diversity of gut microbes and decreases molecular signs of inflammation, according to researchers at the Stanford School of Medicine. In… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.